2021-01-26 |
2021-01-26 |
B
Purchase
|
BridgeBio Pharma, Inc.
Large shareholder
|
14,428,836
0.00
USD 0
|
14,428,836
|
0.00
|
USD 0
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
300
-0.1%
126.39
USD 37,917
|
300
-0.1%
|
126.39
|
USD 37,917
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
2,000
-0.6%
125.35
USD 250,700
|
2,000
-0.6%
|
125.35
|
USD 250,700
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
4,934
-1.6%
124.72
USD 615,362
|
4,934
-1.6%
|
124.72
|
USD 615,362
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
1,498
-0.5%
123.48
USD 184,971
|
1,498
-0.5%
|
123.48
|
USD 184,971
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
572
-0.2%
122.27
USD 69,937
|
572
-0.2%
|
122.27
|
USD 69,937
|
|
2021-01-15 |
2021-01-13 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
696
-0.2%
121.11
USD 84,292
|
696
-0.2%
|
121.11
|
USD 84,292
|
|
2021-01-13 |
2021-01-12 |
S
Sale
|
Valle Franco
Senior Vice President, Finance
Officer
|
1,747
-100.0%
125.45
USD 219,152
|
1,747
-100.0%
|
125.45
|
USD 219,152
|
|
2021-01-13 |
2021-01-11 |
S
Sale
|
Valle Franco
Senior Vice President, Finance
Officer
|
1,500
-100.0%
125.61
USD 188,408
|
1,500
-100.0%
|
125.61
|
USD 188,408
|
|
2020-12-16 |
2020-12-15 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
3,493
-6.5%
112.97
USD 394,589
|
3,493
-6.5%
|
112.97
|
USD 394,589
|
|
2020-12-16 |
2020-12-15 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
11,445
-17.5%
112.19
USD 1,284,018
|
11,445
-17.5%
|
112.19
|
USD 1,284,018
|
|
2020-12-16 |
2020-12-15 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
7,600
-10.4%
111.31
USD 845,937
|
7,600
-10.4%
|
111.31
|
USD 845,937
|
|
2020-12-16 |
2020-12-15 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
3,756
-4.9%
110.29
USD 414,251
|
3,756
-4.9%
|
110.29
|
USD 414,251
|
|
2020-12-04 |
2020-12-02 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
200
-0.1%
92.97
USD 18,593
|
200
-0.1%
|
92.97
|
USD 18,593
|
|
2020-12-04 |
2020-12-02 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
300
-0.1%
91.89
USD 27,567
|
300
-0.1%
|
91.89
|
USD 27,567
|
|
2020-12-04 |
2020-12-02 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
702
-0.2%
90.63
USD 63,625
|
702
-0.2%
|
90.63
|
USD 63,625
|
|
2020-12-04 |
2020-12-02 |
PS
Planned sale
|
Sinha Uma
Chief Scientific Officer
Executive Director
|
3,798
-1.2%
89.63
USD 340,402
|
3,798
-1.2%
|
89.63
|
USD 340,402
|
|
2020-11-13 |
2020-11-11 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
908
-1.7%
75.23
USD 68,308
|
908
-1.7%
|
75.23
|
USD 68,308
|
|
2020-11-13 |
2020-11-11 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
9,497
-15.2%
74.75
USD 709,860
|
9,497
-15.2%
|
74.75
|
USD 709,860
|
|
2020-11-13 |
2020-11-11 |
S
Sale
|
Turtle Cameron
Chief Business Officer
Officer
|
3,005
-4.6%
73.56
USD 221,060
|
3,005
-4.6%
|
73.56
|
USD 221,060
|
|